Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design

Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air–blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-19) have been encountered with a high risk of ARDS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Qi, Liu, Xiong, Yang, Ting, Cui, Kexin, Kong, Li, Yang, Conglian, Zhang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102084/
https://www.ncbi.nlm.nih.gov/pubmed/33977080
http://dx.doi.org/10.1016/j.apsb.2021.04.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102084/
https://www.ncbi.nlm.nih.gov/pubmed/33977080
http://dx.doi.org/10.1016/j.apsb.2021.04.023

Ejemplares similares